Clearside Biomedical Inc. (NASDAQ: CLSD)
$1.22
-0.0250 ( -2.02% ) 185.5K
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Market Data
Open
$1.22
Previous close
$1.24
Volume
185.5K
Market cap
$91.17M
Day range
$1.19 - $1.25
52 week range
$0.65 - $2.12
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 28, 2023 |
10-q | Quarterly Reports | 60 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
8-k | 8K-related | 12 | Nov 03, 2023 |
4 | Insider transactions | 1 | Nov 01, 2023 |
3 | Insider transactions | 1 | Nov 01, 2023 |
4 | Insider transactions | 1 | Oct 04, 2023 |
8-k | 8K-related | 12 | Sep 29, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |
4 | Insider transactions | 1 | Sep 22, 2023 |